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Abstract
Pancreatitis-associated protein (PAP) was discovered in 
the pancreatic juice of rats with acute pancreatitis. PAP 
is a 16 kDa secretory protein structurally related to the 
C-type lectins although classical lectin-related function 
has not been reported yet. Then, it was demonstrated 
that PAP expression may be activated in some tissues 
in a constitutive or injury- and inflammation-induced 
manner. More recently, it has been found that PAP 
acts as an anti-infl ammatory factor in vitro  and in vivo . 
PAP expression can be induced by several pro- and 
anti-inflammatory cytokines and by itself through a 
JAK/STAT3-dependent pathway. PAP is able to activate 
the expression of the anti-inflammatory factor SOCS3 
through the JAK/STAT3-dependent pathway. The 
JAK/STAT3/SOCS3 pathway seems to be a common 
point between PAP and several cytokines. Therefore, 
it is reasonable to propose that PAP is a new anti-
infl ammatory cytokine.
© 2007 The WJG Press. All rights reserved.
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INTRODUCTION
In 1984, Keim and co-workers reported the presence of  
a new protein in pancreatic juice of  rats after induction 
of  acute pancreatitis[1]. This secretory protein was 
absent in control rats but appeared early after induction 
of  pancreatitis and remained over-expressed for the 
following 3-4 d. The protein was detected also in pancreas 
homogenate and in zymogen granules. Due to the 
relationship with the induction of  pancreatitis, the protein 
was denominated “pancreatitis associated protein” or PAP. 
Four years later, Tachibana and colleagues described the 
peptide 23 as a protein from the rat pituitary gland, which 
synthesis was stimulated by the growth hormone-releasing 
hormone and inhibited by somatostatin[2] but its primary 
structure remained unresolved at the time. The sequence 
of  PAP was deduced after cloning the corresponding 
mRNA from rat[3] and human pancreas[4]. Only four years 
later Katsumata and co-workers reported that in fact, 
peptide 23, identified in 1988, was identical to PAP[5]. 
Finally, Lasserre and colleagues found that the PAP mRNA 
was overexpressed in 7 of  29 hepatocellular carcinomas[6] 
and named the encoded protein HIP. Therefore, peptide 
23, HIP and PAP are three names for the same protein. In 
this review we will call it PAP because it is the fi rst name 
adopted for this protein.
In healthy pancreas, PAP is constitutively expressed 
in the α-cells of  Langerhans islets[7]. By contrast, in the 
exocrine pancreas, PAP is only expressed when the acinar 
cells are harmed[4]. In fact, PAP expression is activated in 
pancreatic acinar cells in response to many injuries such 
as acute and chronic pancreatitis[4], hypoxia[8], toxins[9], 
diabetes[10], lipopolysaccharides[11], hypotransferrinaemia[12], 
and in the transplanted tissue[13]. However, its expression is 
not restricted to pancreatic tissue, and could be observed 
in several organs. This includes the intestine during 
chronic infl ammatory diseases such as Crohn’s disease and 
ulcerative colitis[14,15] and in animal models of  infl ammatory 
bowel disease (IBD)[16]. PAP is also expressed in the 
brain tissue of  Alzheimer patients[17,18], in the luminal 
epithelial cells of  the uterus[19] and in a sub-population 
of  developing motoneurons and, after peripheral injury, 
in sensory neurons and motoneurons[20,21]. Moreover, 
PAP mRNA expression was found activated in about 
80% of  the pancreatic adenocarcinomas of  ductal origin 
and in 30% of  mucinous cystadenomas[22]. The levels of  
PAP mRNA expression correlated with nodal invasion, 
presence of  distant metastases and short survival. Also, 
in some cases peritumoral regions overexpressed PAP[23], 
indicating that both tumor and peritumoral cells contribute 
to the high PAP serum level observed in patients with 
pancreatic cancer. In the liver, PAP was found strongly 
activated in about 30% of  the primary hepatocarcinomas, 
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but the forced expression of  PAP in this organ does not 
induce tumor development[24].
PAP IS A LECTIN-RELATED PROTEIN
Computer analysis of  the PAP sequence suggests a 
structural relationship with lectins[3]. Identities between 
PAP and the other animal and human lectins range 
from 16% to 26%. Homologous domain includes the 
conserved amino acids of  the consensus carbohydrate 
binding domain of  the Ca2+-dependent lectins (C-type 
lectins) (Figure 1). However, initial attempts to characterize 
a carbohydrate binding activity, including erythrocyte 
agglutination or adsorption to affinity columns specific 
for different carbohydrates, failed[3]. The structural 
organization of  the PAP gene reveals new clues to the 
evolutionary development of  the lectin genes. The PAP 
coding sequence spans over six exons and the putative 
carbohydrate-recognition domain is encoded by exons 
?, ? and ?. This gene organization suggests that PAP 
belongs to a new group of  lectins which have evolved 
from the same carbohydrate-recognition domain ancestral 
precursor through a different process[25]. It is interesting to 
note that PAP is the smallest protein reported among the 
C-type lectins. In fact, it comprises a single carbohydrate-
recognition domain linked to a signal peptide[26] whereas 
other C-type lectins contain the sugar-binding consensus 
combined with a variety of  other protein domains which 
confer specifi c functions of  lectins. In contrast, PAP does 
not have additional functional domains.
PAP IN PANCREATIC DISEASES
Early after its discovery it becomes clear that acinar 
cells of  the pancreas are the main source of  PAP in 
pathological situations. Using an experimental model of  
acute pancreatitis in rat, Morisset and co-workers found 
the induction of  PAP and its localization in zymogen 
granules[27]. Bodeker and co-workers described the pattern 
of  PAP up-regulation in exocrine pancreas during the 
progression of  the disease[28]. The profiles obtained by 
Northern blot analysis with pancreatic RNAs, Western 
blot in pancreatic protein extracts and immunodetection 
are equivalent to that observed in human disease and in 
animal models. The absence of  PAP in healthy pancreas 
and its strong induction observed during the early phase 
of  the disease suggest that PAP could be a stress protein 
or an acute phase protein induced upon cell insult. This 
is of  interest since pancreatic acute phase response, 
characterized by sudden changes in protein expression is 
a clear indicator of  injury or infections in the pancreatic 
gland. Since PAP is overexpressed by pancreatic cells in 
response to cellular stress, it has been evaluated whether 
serum PAP could be an indicator of  different pancreatic 
diseases. In an initial retrospective study[29], it has been 
suggested that PAP might be a useful serum marker in the 
following of  acute pancreatitis. In particular, a continuous 
elevation of  serum PAP concentrations indicates that 
pancreatitis is still in progress. Nevertheless, other studies 
revealed that despite severity of  pancreatitis correlated with 
serum levels of  PAP, the sensitivity of  PAP did not allow 
distinguishing severe from mild acute pancreatitis, better 
than C reactive protein[30]. In the case of  pancreatic cancer, 
PAP was also overexpressed and could be observed in 
malignant ductular structures in pancreatic carcinomas[22]. 
Other reports revealed that PAP was strongly expressed in 
acini adjacent to the invasive adenocarcinoma, suggesting 
that the main source of  PAP release in the pancreatic 
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juice is acini[23]. Since overexpression of  PAP signifi cantly 
correlated with nodal involvement, distant metastasis, and 
short survival, it has been suggested that its expression 
in human pancreatic ductal adenocarcinoma could be an 
indicator of  tumor aggressiveness[22].
PHYSIOLOGICAL FUNCTIONS OF PAP
The fact that PAP is secreted by pancreatic acinar cells into 
the pancreatic juice initially suggested a role for this protein 
in pancreatic juice homeostasis. Several data are in line with 
this. Pancreatic juice is supersaturated in CaCO3 and, in the 
absence of  physiological inhibitors, this salt will precipitate 
in crystal formation. Interestingly, lithostathine, another 
member of  the PAP protein family, inhibits CaCO3 crystal 
growth in vitro[31]. On the other hand, it has been shown 
that PAP can bind and aggregate several bacterial strains 
from the intestinal fl ora including Gram positive and Gram 
negative, aerobic and anaerobic bacteria, although without 
inhibiting their growth[3]. This fact suggests that PAP could 
act as an endogenous anti-bacterial agent that could play a 
protective role preventing infectious complications in acute 
pancreatitis. Another suggested function for PAP is related 
to the fact that PAP conferred significant resistance to 
apoptosis induced by TNFα[32] or by low doses of  H2O2[33], 
indicating that during acute pancreatitis PAP generation 
could be part of  a mechanism of  pancreatic cell protection 
against apoptosis. This anti-apoptotic effect of  PAP was 
also observed in liver in which PAP protects hepatocytes 
against TNFα-induced apoptosis[24]. An interesting role for 
PAP has also been observed in motoneurons. It has been 
reported that PAP expression is activated in developing 
and regenerating motoneurons[20]. This effect is related to 
ciliary neurotrophic factor (CNTF), which is an important 
survival factor for motoneurons. In cultured motoneurons, 
CNTF induces PAP expression which acts as an autocrine/
paracrine neurotrophic factor in a subpopulation of  
motoneurons, by stimulating a survival pathway involving 
PI3 kinase, Akt kinase and NFκB[34]. Despite the obvious 
interest of  these observations, it is diffi cult to link these 
effects with the enormous amount of  PAP released 
by pancreas during acute pancreatitis or cellular stress. 
Consequently, other physiological functions, more closely 
related with pancreatic diseases, have been investigated.
PAP AS AN ANTI-INFLAMMATORY
MEDIATOR
The initial indication that PAP could act as a modulat 
or of  the inflammatory response has been provided 
by Heller and co-workers[35]. Using an ex-vivo model 
of  lung perfusion, these authors observed that PAP 
reduces the severity of  some features associated with 
N-formyl-methionyl-leucyl-phenyl-alanine (FMLP)-
induced activation of  leukocytes. This includes the 
generation of  thromboxane B2 and the tissue edema 
formation in the lung. Since PAP generation has been 
observed in diseases related with infl ammatory processes 
(pancreatitis, Crohn’s disease, etc.), it was speculated that 
PAP could act as a cell response to the inflammatory 
stress. This is in line with the fact that induction in the 
pancreas of  an acute-phase response, in which PAP 
expression was activated, prior to triggering necrotizing 
pancreatitis, significantly improved the survival of  the 
animals[36]. Studies demonstrated that the administration 
of  anti-PAP antibodies in an experimental model of  
taurocholate-induced acute pancreatitis in rats was 
associated with increased inflammation in the pancreas, 
evidenced by more abundant necrosis, increased pancreatic 
myeloperoxidase (MPO) levels and more prominent 
neutrophil infi ltration[37]. Similar results were observed in 
another study using PAP antisense oligodeoxyribonucle
otides to block the expression of  PAP prior to induction 
of  pancreatitis. With this approach, pancreatitis-induced 
PAP expression was reduced by 55% and markers of  
inflammatory cell damage were increased. These include 
serum amylase activity, pancreas edema, serum C-reactive 
protein, leukocyte infi ltration and fat necrosis. In addition, 
the expression of  IL-1α , IL-1β  and IL-4 was increased in 
peripheral blood mononuclear cells[38]. Pre-treatment with 
PAP of  the in vitro TNFα-stimulated macrophages results 
in a dose-dependent inhibition of  IL-6 and TNFα  mRNA 
expression[37]. The inhibitory effect of  PAP has been 
observed in different cell lines, including rat pancreatic 
acinar AR42J cells and human HT29 colon derived cells[39]. 
In these models, PAP prevented NFκB translocation/activation 
in response to TNFα, indicating that inhibition by PAP 
occurs, at least in part, upstream of  NFκB pathway. It is 
of  clinical interest that the anti-inflammatory effect of  
PAP could be observed in other organs than pancreas. 
For example, increased serum levels of  PAP expression 
has been observed in IBD-affected patients and these 
levels correlated with clinical and endoscopic parameters. 
In addition, ex vivo experiments showed that intestinal 
PAP synthesis and secretion was increased in active IBD 
and correlated with endoscopic and histological severity 
of  inflammatory lesions. Remarkably, PAP reduced the 
proinflammatory cytokines secretion of  the incubation 
of  intestinal mucosa from active Crohn’s disease in a dose 
dependent manner[39]. Consequently, it could be suggested 
that the anti-infl ammatory role of  PAP is not restricted to 
the pancreas and could be a more general response of  the 
epithelial cells against the infl ammatory processes.
ANTI-INFLAMMATORY ACTIVITY OF PAP 
IS MEDIATED BY STAT3 ACTIVATION
The inhibitory effect of  PAP on the pro-inflammatory 
NFκB pathway seems to be dependent on protein 
synthesis. This has been demonstrated in AR42J cells by 
using cycloheximide into the culture medium to prevent 
de novo protein synthesis[40]. As indicated above, TNFα 
induces overexpression of  the TNFα  gene itself  and this 
autocrine loop could be blocked by PAP. However, PAP 
lost its ability when protein synthesis was inhibited by 
cycloheximide. This protein synthesis dependence to act as 
an anti-infl ammatory factor shows similarities to IL-10 and 
IL-6, which depend in part on the synthesis of  suppressor 
of  cytokine signalling (SOCS) proteins[41,42]. Both IL-10 
and IL-6 receptors are related to the JAK/STAT signal 
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transduction pathways. Therefore, the relationship 
between PAP and JAK/STAT has also been evaluated. In 
a recent paper, it has been reported that PAP treatment 
of  the AR42J cells results in a rapid and transient 
phosphorylation and nuclear translocation of  STAT3 
protein[40]. In addition, pre-treatment with JAK-specific 
inhibitors results in the blockage of  the inhibitory effects 
induced by PAP. Finally, the PAP-dependent activation 
of  STAT3 results in a strong activation of  its gene target 
SOCS3 that in turn could be the mediator of  the PAP anti-
infl ammatory effect. Altogether, these results indicate that 
PAP exerts their effects through the synthesis of  a protein 
induced by the activation of  the JAK/STAT signalling 
pathway. SOCS3 will be the best candidate.
PAP can be strongly induced by IL-6 and IL-10 and 
IL-10-related cytokines through a STAT3-mediated pathway. 
Interestingly, expression of  PAP itself  appears to be 
induced in pancreatic acinar cells by the presence of  PAP 
in the medium. This is also related to the activation of 
STAT3 pathway since at least two functional STAT-responsible 
elements have been reported in the promoter of  the PAP 
gene[43]. This self-induction suggests the existence of  a 
positive feedback mechanism in pancreatic acinar cells via a 
PAP receptor and a cross-talk with other cytokines (Figure 2).
CONCLUDING REMARKS
PAP has been found as a 16 kDa secretory protein 
specifically induced in pancreas with acute pancreatitis. 
It has been demonstrated that PAP is activated in some 
tissues in a constitutive or injury- and inflammation-
induced manner. PAP is structurally related to the C-type 
lectins although not classical lectin-related function has 
been reported. More recently, it has been found that 
PAP acts as an anti-inflammatory factor in vitro and in 
vivo. PAP expression can be induced by several pro- and 
anti-inflammatory cytokines and by itself  through a 
JAK/STAT3-dependent pathway. PAP is able to activate the 
expression of  the anti-infl ammatory factor SOCS3 through 
the JAK/STAT3-dependent pathway. JAK/STAT3/SOCS3 
pathway seems to be a common point between PAP and 
several cytokines. Therefore, it is reasonable to believe that 
PAP is a new anti-infl ammatory cytokine.
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